See on Scoop.it – Prostate Cancer Updates
“Contrary to the standard approach to treating metastatic prostate cancer, direct treatment of the primary tumor appears to prolong survival significantly, a new study by researchers at the University of Virginia School of Medicine and Norfolk’s Eastern Virginia Medical School suggests. The surprising findings have prompted the researchers to launch clinical trials that could upend the accepted treatment of the disease.
“Prostate cancer is the most common form of cancer in American men and the second-leading cause of cancer death in men. Localized prostate cancer – meaning the cancer is contained within the prostate – has a five-year survival rate of almost 100 percent. But that number drops dramatically if the cancer is metastatic, meaning it has spread beyond the prostate. In that case, five-year survival is only 28 percent.”
See on medicalxpress.com